TuHURA Biosciences
Yahoo Finance • 2 months ago
Unusual volume stocks are being observed in Wednesday's session.
Which stocks have an unusual volume on Wednesday? [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT ADN [https://www.chartmill.com/stock/quote/ADN/profile] 4.49% ADVENT TECHNOLOGIES HOLDINGS'S (NASDAQ:ADN [h... Full story
Yahoo Finance • 3 months ago
TuHURA Biosciences added to Russell 3000 and 2000 indexes
TAMPA - TuHURA Biosciences, Inc. (NASDAQ:HURA), a Phase 3 immune-oncology company, has been added to the Russell 3000 and Russell 2000 indexes as part of the 2025 annual reconstitution, effective June 27, 2025. The company, currently value... Full story
Yahoo Finance • 3 months ago
TuHURA Biosciences completes acquisition of Kineta, adds VISTA inhibitor
TAMPA - TuHURA Biosciences, Inc. (NASDAQ:HURA), a clinical-stage biotech with a market capitalization of $97 million, announced Monday the completion of its acquisition of Kineta, Inc. (OTCPK:KANT), adding a Phase 2 ready VISTA inhibiting... Full story
Yahoo Finance • 3 months ago
TuHURA initiates phase 3 trial for cancer immunotherapy drug
TAMPA - TuHURA Biosciences, Inc. (NASDAQ:HURA), a clinical-stage biotech company with a market capitalization of $110.5 million, has initiated a Phase 3 trial of its lead drug candidate IFx-2.0 in patients with advanced or metastatic Merke... Full story
Yahoo Finance • 3 months ago
TuHURA Biosciences and Kineta stockholders approve proposed deal
[word m and a made with wood building blocks, stock image] Maksim Labkouski/iStock via Getty Images * TuHURA Biosciences (NASDAQ:HURA [https://seekingalpha.com/symbol/HURA]) said that its stockholders have approved the proposed merger w... Full story
Yahoo Finance • 4 months ago
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of OPOF, PRA, SWTX and HURA to Take Action
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services... Full story
